Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
6
×
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
eli lilly
sanofi
abbvie
alexion pharmaceuticals
boehringer ingelheim
boston
congress
deals
gene therapy
gilead sciences
glaxosmithkline
What
pharma
6
×
drug
bio
dicerna
executives
medicines
roundup
abandoning
abbvie’s
administration
ago
ahead
angry
anti
away
baggage
benefited
biofourmis
biopharma
bringing
bucks
cancer
caught
causing
celebrate
ceos
chance
companies
congress
congressional
corner
crispr
cuts
day
days
dc
deal
despite
development
disease
Language
unset
Current search:
pharma
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M